Medifast, Inc.
MED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $2 |
| Revenue | $1 | $1 | $2 | $2 |
| % Growth | -43.8% | -32.9% | 4.8% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 73.8% | 72.4% | 71.3% | 73.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 2.6% | 13% | 12.2% | 14.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 0.3% | 9.3% | 9% | 10.7% |
| EPS Diluted | 0.19 | 9.1 | 12.73 | 13.89 |
| % Growth | -97.9% | -28.5% | -8.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |